All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-D-0207
E22 General Considerations for Patient Preference Studies; International Council for Harmonisation; Draft Guidance for Industry; Availability
Documents
2
Comments
12
Description
Open
Key Dates
Comment Period OpensFeb 6, 2026
Comment Period ClosesApr 8, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Comment Statistics
Total Comments
12
Keywords
CDER
FRDTS # 2025-314
E22 General Considerations for
Patient Preference Studies
International Council for Harmonisation
Draft Guidance for Industry; Availability
Open
Data from Regulations.gov